tiprankstipranks
Trending News
More News >
Anagenics Limited (AU:AN1)
ASX:AN1
Australian Market

Anagenics (AN1) Price & Analysis

Compare
0 Followers

AN1 Stock Chart & Stats

Currently, no data available

Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.82%98.18%
Mutual Funds
― Other Institutional Investors
98.18% Public Companies and
Individual Investors

AN1 FAQ

What was Anagenics Limited’s price range in the past 12 months?
Currently, no data Available
What is Anagenics Limited’s market cap?
Anagenics Limited’s market cap is AU$3.69M.
    When is Anagenics Limited’s upcoming earnings report date?
    Anagenics Limited’s upcoming earnings report date is Aug 28, 2025 which is in 77 days.
      How were Anagenics Limited’s earnings last quarter?
      Anagenics Limited released its earnings results on Feb 27, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
        Is Anagenics Limited overvalued?
        According to Wall Street analysts Anagenics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Anagenics Limited pay dividends?
          Anagenics Limited does not currently pay dividends.
          What is Anagenics Limited’s EPS estimate?
          Anagenics Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Anagenics Limited have?
          Currently, no data Available
          What happened to Anagenics Limited’s price movement after its last earnings report?
          Anagenics Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
            Which hedge fund is a major shareholder of Anagenics Limited?
            Currently, no hedge funds are holding shares in AU:AN1

            Anagenics Stock Smart Score

            Company Description

            Anagenics Limited

            Anagenics Limited operates as a health and beauty-tech company in Australia, New Zealand, Japan, and internationally. The company develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. It markets its products through various channels, including e-commerce, television shopping, wholesale pharmacy and salons, and cross border export markets. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
            Similar Stocks
            Company
            Price & Change
            Follow
            Celsius Resources
            Celexpress
            Creative Medical Technology Holdings
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis